Der Human Monoklonal anti-WNV Core Antikörper wird verwendet zum Nachweis von WNV Core in Proben von West Nile Virus (WNV). Er wurde validiert für ELISA, WB und SPR.
WNV Core
Reaktivität: West Nile Virus (WNV)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4.
Lagerung
-20 °C,-80 °C
Informationen zur Lagerung
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
Target
WNV Core
(West Nile Virus Genome polyprotein (WNV Core))
Andere Bezeichnung
WNV GP1
Substanzklasse
Viral Protein
Hintergrund
Genome polyprotein, Peptide 2k, Capsid protein C, Core protein, Protein prM, Peptide pr, Small envelope protein M, Matrix protein, Envelope protein E, Non-structural protein 1, NS1, Non-structural protein 2A, NS2A, Serine protease subunit NS2B, Flavivirin protease NS2B regulatory subunit, Non-structural protein 2B, Serine protease/Helicase NS3, 3.4.21.91, 3.6.1.15, 3.6.4.13, Flavivirin protease NS3 catalytic subunit, Non-structural protein 3, Non-structural protein 4A, NS4A, Non-structural protein 4B, NS4B, RNA-directed RNA polymerase NS5, 2.1.1.56, 2.1.1.57, 2.7.7.48, NS5, GP1, MZ11_60484gpGP1, MZ11_60553gpGP1, West Nile virus (strain NY-99) (WNV) (West Nile virus (strain NY-1999))